Core Laboratories N.V.
CLB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.4% | 5.3% | -4.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 19.3% | 17.5% | 16.5% | 15% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 18.2% | 17.4% | 6.6% | 13.8% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 10.6% | 8.2% | -0.1% | 5.7% |
| EPS Diluted | 0.3 | 0.22 | -0.003 | 0.16 |
| % Growth | 36.4% | 6,766.7% | -102.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |